Now hiring: Two PhD Students in Molecular Pharmaceutics

2022-01-31

SweDeliver is now recruiting two PhD Students in Molecular Pharmaceutics. Welcome to submit your application no later than 18 February 2022.

Two PhD Students at SweDeliver

In spring 2022 SweDeliver will launch the projects Effects of molecular characteristics of macromolecular drugs and permeation enhancer on oral absorption and In vivo dissolution in colon of poorly water-soluble drugs. Prior to the launch we are now recruiting two PhD Students to join our world leading research forum.


As PhD Student in the project Effects of molecular characteristics of macromolecular drugs and permeation enhancer on oral absorption you will study and elucidate factors of importance for drug delivery of macromolecular drugs in the beyond-rule-of-5 chemical space, and how to combine such compounds with permeation enhancer to increase fraction absorbed.


As PhD Student in the project In vivo dissolution in colon of poorly water-soluble drugs you will conduct studies aiming to improve the understanding of dissolution of poorly water-soluble compounds in colon. The generated knowledge will be used for developing physiologically relevant in silico and in vitro models that will improve our understanding of how to design successful dosage forms for efficient colonic release and absorption.

FACTS SWEDELIVER

SweDeliver is a national competence center in drug delivery. With Uppsala University's Faculty of Pharmacy as the academic hub and 16 industrial partners, SweDeliver conducts research on parenteral, oral and pulmonary administration.

CONTACT

Christel Bergström
Center Director, SweDeliver
Christel.Bergstrom@farmaci.uu.se

Currently at SweDeliver

Last modified: 2022-03-31